Asthma and allergy: Short texts and recommendations of the expert conference of the French Speaking Pneumology Society (SPLF), in partnership with the French Society of Allergology and Clinical Immunology (SFAIC), the French Society of Occupational Medicine (SFMT) and the "Asthma-Allergy" association

Respiratory Medicine

Volumn 102, Issue 10, 2008, Pages 1483-1493

  Tillie Leblond, Isabelle ^a   Magnan, Antoine ^b   Pauli, Gabrielle ^c   Vervloet, Daniel ^b   Wallaert, Benoît ^a   Didier, Alain ^d   Ameille, Jacques ^e   Godard, Philippe ^f   the group of experts, ^g  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

^c HÔPITAL CIVIL   (France)

^d SERVICE DE PNEUMOLOGIE   (France)

^e RAYMOND POINCARÉ HOSPITAL   (France)

^f HÔPITAL ARNAUD DE VILLENEUVE   (France)

^g NONE

Author keywords

Allergy; Asthma; Exploration; Recommendations

Indexed keywords

ALLERGEN; CONTRAST MEDIUM; IMMUNOGLOBULIN E ANTIBODY; IODINE CONTAINING CONTRAST MEDIA; MUSCLE RELAXANT AGENT; OMALIZUMAB; PENICILLIN DERIVATIVE; UNCLASSIFIED DRUG;

AIRWAY OBSTRUCTION; ALLERGY; ALLERGY TEST; ANAPHYLAXIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; ATOPY; BLOOD SAMPLING; BRONCHOSPASM; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; ECZEMA; EXPOSURE; FOLLOW UP; FOOD ALLERGY; FORCED EXPIRATORY VOLUME; FRANCE; GENETIC PREDISPOSITION; GENOTYPE ENVIRONMENT INTERACTION; GROUPS BY AGE; HEALTH EDUCATION; HUMAN; HYMENOPTERA; IMMUNOTHERAPY; LIFESTYLE MODIFICATION; LUNG FUNCTION TEST; MITE; OCCUPATIONAL ASTHMA; OCCUPATIONAL HAZARD; OTORHINOLARYNGOLOGY; PEAK EXPIRATORY FLOW; PHYSICAL EXAMINATION; PREVALENCE; PREVENTION; PRICK TEST; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RHINITIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SENSITIZATION; SMOKING; SYMPTOM; VACCINATION REACTION; WORK ENVIRONMENT; X RAY;

ADULT; ANTI-ALLERGIC AGENTS; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; FRANCE; HUMANS; HYPERSENSITIVITY; OCCUPATIONAL MEDICINE; PULMONARY MEDICINE; TOBACCO SMOKE POLLUTION;

EID: 50549087757     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.03.002     Document Type: Article

References (78)

1. An exhaustive list of all references is available in the manuscript of the expert conference (long text) La conférence d'experts de la Société de Pneumologie de Langue Française (SPLF) sur Asthme et Allergie, Rev Mal Respir, in press.
2. Sherrill D.L., Stein R., Halonen M., Holberg C.J., Wright A., and Martinez F.D. Total serum IgE and its association with asthma symptoms and allergic sensitization among children. J Allergy Clin Immunol 104 (1999) 28-36
3. Boulet L.P., Turcotte H., Laprise C., Lavertu C., Bedard P.M., Lavoie A., et al. Comparative degree and type of sensitization to common indoor and outdoor allergens in subjects with allergic rhinitis and/or asthma. Clin Exp Allergy 27 (1997) 52-59
4. Al-Mousawi M.S., Lovel H., Behbehani N., Arifhodzic N., Woodcock A., and Custovic A. Asthma and sensitization in a community with low indoor allergen levels and low pet-keeping frequency. J Allergy Clin Immunol 114 (2004) 1389-1394
5. Zureik M., Neukirch C., Leynaert B., Liard R., Bousquet J., and Neukirch F. European Community Respiratory Health Survey. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ 325 (2002) 411-414
6. Lewis S.A., Weiss S.T., Platts-Mills T.A., Burge H., and Gold D.R. The role of indoor allergen sensitization and exposure in causing morbidity in women with asthma. Am J Respir Crit Care Med 165 (2002) 961-966
7. Gruchalla R.S., Pongracic J., Plaut M., Evans III R., Visness C.M., Walter M., et al. Inner City asthma study: relationships among sensitivity, allergen exposure, and asthma morbidity. J Allergy Clin Immunol 115 (2005) 478-485
8. Matheson M.C., Abramson M.J., Dharmage S.C., Forbes A.B., Raven J.M., Thien F.C., et al. Changes in indoor allergen and fungal levels predict changes in asthma activity among young adults. Clin Exp Allergy 35 (2005) 907-913
9. Gehring U., Heinrich J., Jacob B., Richter K., Fahlbusch B., Schlenvoigt G., et al. Respiratory symptoms in relation to indoor exposure to mite and cat allergens and endotoxins. Eur Respir J 18 (2001) 555-563
10. Langley S.J., Goldthorpe S., Craven M., Woodcock A., and Custovic A. Relationship between exposure to domestic allergens and bronchial hyperresponsiveness in non-sensitised, atopic asthmatic subjects. Thorax 60 (2005) 17-21
11. Pepe C., Foley S., Shannon J., Lemiere C., Olivenstein R., Ernst P., et al. Differences in airway remodeling between subjects with severe and moderate asthma. J Allergy Clin Immunol 116 (2005) 544-549
12. Bernstein I.L., and Storms W.W. Practice parameters for allergy diagnostic testing. Joint Task Force on Practice Parameters for the Diagnosis and Treatment of Asthma. The American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 75 (1995) 543-625
13. Tschopp J.M., Sistek D., Schindler C., Leuenberger P., Perruchoud A.P., Wüthrich B., et al. Current allergic asthma and rhinitis: diagnostic efficiency of three commonly used atopic markers (IgE, skin prick tests, and Phadiatop). Results from 8329 randomized adults from the SAPALDIA Study. Swiss study on air pollution and lung diseases in adults. Allergy 53 (1998) 608-613
14. Demoly P., Michel F.B., and Bousquet J. In vivo methods for study of allergy: skin tests, techniques and interpretation. In: Middleton E., Reed C.E., Ellis E.F., Adkinson Jr. N.F., and Yunginger J.W. (Eds). Allergy, Principles and practice. 4th ed. (1998), Mosby Co, New York 430-439
15. Adinoff A.D., Rosloniec D.M., McCall L.L., and Nelson H.S. Immediate skin test reactivity to Food and Drug Administration-approved standardized extracts. J Allergy Clin Immunol 86 (1990) 766-774
16. Skassa-Brociek W., Manderscheid J.C., Michel F.B., and Bousquet J. Skin test reactivity to histamine from infancy to old age. J Allergy Clin Immunol 80 (1987) 711-716
17. Ménardo J.L., Bousquet J., Rodière M., Astruc J., and Michel F.B. Skin test reactivity in infancy. J Allergy Clin Immunol 75 (1985) 646-651
18. Position paper: Allergen standardization and skin tests. The European Academy of Allergology and Clinical Immunology. Allergy 48 (1993) 48-82
19. Bousquet J., Chanez P., Chanal I., and Michel F.B. Comparison between RAST and Pharmacia CAP system: a new automated specific IgE assay. J Allergy Clin Immunol 85 (1990) 1039-1043
20. Wood R.A., Phipatanakul W., Hamilton R.G., and Eggleston P.A. A comparison of skin prick tests, intradermal skin tests, and RASTs in the diagnosis of cat allergy. J Allergy Clin Immunol 103 (1999) 773-779
21. Kerkhof M., Dubois A.E., Postma D.S., Schouten J.P., and de Monchy J.G. Role and interpretation of total serum IgE measurements in the diagnosis of allergic airway disease in adults. Allergy 58 (2003) 905-911
22. Burrows B., Martinez F.D., Halonen M., Barbee R.A., and Cline M.G. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 320 (1989) 271-277
23. Metz-Favre C., Birba E., Métivier A.C., De Blay F., and Pauli G. Intérêt du dosage des IgE vis-à-vis de l'allergène recombinant rBet v 1 dans la prise en charge de la pollinose printanière. Rev Fr Allergol Immunol Clin 45 (2005) 584-589
24. Siroux V., Curt F., Oryszczyn M.P., Maccario J., and Kauffmann F. Role of gender and hormone related events on IgE, atopy, and eosinophils in the epidemiological study on the genetics and environment of asthma, bronchial hyperresponsiveness and atopy. J Allergy Clin Immunol 114 (2004) 491-498
25. Tillie-Leblond I., and Tonnel A.B. Allergic bronchopulmonary aspergillosis. Allergy 60 (2005) 1004-1005
26. Plebani M., Borghesan F., Basso D., and Faggian D. Receiver-operating characteristic (ROC) curves: a fundamental tool for improving the clinical usefulness of in vitro IgE tests. Allergy 51 (1996) 407-411
27. Lewis S.A., Pavord I.D., Stringer J.R., Knox A.J., Weiss St M.D., and Britton J.R. The relation between peripheral blood leukocyte counts and respiratory symptoms, atopy, lung function, and airway responsiveness in adults. Chest 119 (2001) 105-114
28. Gleich G.J. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 105 (2000) 651-663
29. Mertes P.M., Laxenaire M.C., and GERAP. Anaphylactic and anaphylactoid reactions occurring during anaesthesia in France. Seventh epidemiologic survey (January 2001-December 2002). Ann Fr Anesth Reanim 23 (2004) 1133-1143
30. Charpin D., Benzarti M., Hémon Y., Senft M., Arnaud A., Vervloet D., et al. Atopy and systemic reactions to suxamethonium. J Allergy Clin Immunol 82 (1988) 356-360
31. Kari B., Davis R.L., Marcy S.M., Braun M.M., DeStefano F., Black S.B., et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 112 (2003) 815-820
32. Co Minh H.B., Bousquet J.P., Fontaine C., Kvedarienne V., and Démoly P. Systemic reaction during skin tests with beta-lactam: a risk factor analysis. J Allergy Clin Immunol 117 (2006) 466-468
33. Torres M.J., Blanca M., Fernabdez J., Romano A., De Weck A., Aberer W., et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 58 (2003) 961-972
34. Müller U. Epidemiology of insect sting allergy. Monogr Allergy 31 (1993) 131-146
35. Annila I.T., Karjalainen E.S., Mörsky P., and Kuusisto P.A. Clinical symptoms and immunologic reactivity to bee and wasp strings in beekeepers. Allergy 50 (1995) 568-574
36. Taragin B.H., and Newhouse J.H. Pretreatment of patients with asthma who are administered low-osmolar contrast material. Am J Roentgenol 177 (2001) 1211-1212
37. Sampson H.A., Munoz-Furlong A., Campbell R.L., Adkinson Jr. N.F., Bock S.A., and Branum A. Second symposium on the definition and management of anaphylaxis: summary report - Second National Institute of Allergy and Infectious Disease/Food Allergy and AnaphylaxisNetwork symposium. J Allergy Clin Immunol 117 (2006) 391-397
38. Bousquet J., Van Cauwenberge P., Khaltaev N., and Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108 (2001) S147-S334
39. Bousquet J., Gaugris S., Kocevar V.S., Zhang Q., Yin D.D., Polos P.G., and Bjermer L. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis. Clin Exp Allergy 35 (2005) 723-727
40. Kanani A.S., Broder I., Greene J.M., and Tarlo S.M. Correlation between nasal symptoms and asthma severity in patients with atopic and nonatopic asthma. Ann Allergy Asthma Immunol 94 (2005) 341-347
41. Spector S.L., Nicklas R.A., Chapman J.A., Bernstein I.L., Berger W.E., Blessing-Moore J., et al. Symptom severity assessment of allergic rhinitis. Ann Allergy Asthma Immunol 91 (2003) 105-114
42. Juniper E.F., Thompson A.K., Ferrie P.J., and Roberts J.N. Validation of the standardized version of the rhinoconjunctivitis quality of life questionnaire. J Allergy Clin Immunol 104 (1999) 364-369
43. Corren J., Manning B.E., Thompson S.F., Hennessy S., and Strom B.L. Rhinitis therapy and the prevention of hospital care for asthma: a case-control study. J Allergy Clin Immunol 113 (2004) 415-419
44. Raherison C., Montaudon M., Stoll D., Wallaert B., Darras J., Chanez P., et al. How should nasal symptoms be investigated in asthma? A comparison of radiologic and endoscopic findings. Allergy 59 (2004) 821-826
45. Spergel J.M., and Paller A.S. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 112 Suppl. (2003) S118-S127
46. Practice parameters for allergen immunotherapy. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. J Allergy Clin Immunol 98 (1996) 1001-1011
47. Abramson M.J., Puy R.M., and Weiner J.M. Allergen immunotherapy for asthma. Cochrane Database Syst Rev 4 (2003) CD001186
48. Durham S.R., Walker S.M., Varga E.M., Jacobson M.R., O'Brien O., Noble W., et al. Long term clinical efficacy of grass-pollen immunotherapy. New Engl J Med 341 (1999) 468-475
49. Wilson D.R., Lima M.T., and Durham S.R. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2 (2003) CD002893
50. Cox L.S., Linnemann D.L., Nolte H., Weldon D., Finegold I., and Nelson H. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 117 (2006) 1021-1035
51. Calamita Z., Saconato H., Pela A.B., and Attallah A.N. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane collaboration method. Allergy 61 (2006) 1162-1172
52. Humbert M., Beasley R., Ayres J., Slavin R., Hebert J., Bousquet J., et al. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy 60 (2005) 309-316
53. De Blay F., Fourgaut G., Hedelin G., Vervloet D., Michel F.B., Godard P., et al. Medical Indoor Environment Counselor (MIEC): role in compliance with advice on mite allergen avoidance and on mite allergen exposure. Allergy 58 (2003) 27-33
54. Matheson M.C., Abramson M.J., Dharmage S.C., Forbes A.B., Raven J.M., Thien F.C.K., et al. Changes in indoor allergen and fungal levels predict changes in asthma activity among young adults. Clin Exp Allergy 35 (2005) 907-913
55. Chapman M.D., Tsay A., and Vailes L.D. Home allergen monitoring and control-improving clinical practice and patient benefits. Allergy 56 (2001) 604-610
56. Shirai T., Matsui T., Suzuki K., and Chida K. Effect of pet removal on pet allergic asthma. Chest 127 (2005) 1565-1571
57. Vandenplas O., and Malo J.L. Definitions and types of work-related asthma: a nosological approach. Eur Respir J 21 (2003) 706-712
58. Blanc P.D., and Toren K. How much adult asthma can be attributed to occupational factors?. Am J Med 107 (1999) 580-587
59. Balmes J., Becklake M., Blanc P., Henneberger P., Kreiss K., Mapp C., Milton D., Schwartz D., Toren K., and Viegi G. American Thoracic Society Statement: occupational contribution to the burden of airway disease. Am J Respir Crit Care Med 167 (2003) 787-797
60. Karjalainen A., Kurppa K., Martikainen R., Klaukka T., and Karjalainen J. Work is related to a substantial portion of adult-onset asthma incidence in the Finnish population. Am J Respir Crit Care Med 164 (2001) 565-568
61. Johnson A.R., Dimich-Ward H.D., Manfreda J., Becklake M.R., Ernst P., Sears M.R., et al. Occupational asthma in adults in six Canadian communities. Am J Respir Crit Care Med 162 (2000) 2058-2062
62. Arif A.A., Whitehead L.W., Delclos G.L., Tortolero S.R., and Lee E.S. Prevalence and risk factors of work related asthma by industry among United States workers: data from the third national health and nutrition examination survey (1988-94). Occup Environ Med 59 (2002) 505-511
63. Eagan T.M., Gulsvik A., Eide G.E., and Bakke P.S. Occupational airborne exposure and the incidence of respiratory symptoms and asthma. Am J Respir Crit Care Med 166 (2002) 933-938
64. Gannon P.F., and Burge P.S. The SHIELD scheme in the West Midlands Region, United Kingdom. Midland Thoracic Society Research Group. Br J Ind Med 50 (1993) 791-796
65. Meredith S., and Nordman H. Occupational asthma: measures of frequency from four countries. Thorax 51 (1996) 435-440
66. Ameille J., Pauli G., Calastreng-Crinquand A., Vervloet D., Iwatsubo Y., Popin E., et al. Reported incidence of occupational asthma in France, 1996-99: the ONAP programme. Occup Environ Med 60 (2003) 136-141
67. Van Kampen V., Merget R., and Baur X. Occupational airway sensitizers: an overview on the respective literature. Am J Ind Med 38 (2000) 164-218
68. Mapp C.E. Agents, old and new, causing occupational asthma. Occup Environ Med 58 (2001) 354-360
69. Malo J.L., Ghezzo H., L'Archeveque J., Lagier F., Perrin B., and Cartier A. Is the clinical history a satisfactory means of diagnosing occupational asthma?. Am Rev Respir Dis 143 (1991) 528-532
70. Vandenplas O., Ghezzo H., Munoz X Moscato G., Perfetti L., Lemiere C., Labrecque M., et al. What are the questionnaire items most useful in identifying subjects with occupational asthma?. Eur Respir J 26 (2005) 1056-1063
71. Malo J.L., Cote J., Cartier A., Boulet L.P., L'Archeveque J., and Chan-Yeung M. How many times per day should peak expiratory flow rates be assessed when investigating occupational asthma?. Thorax 48 (1993) 1211-1217
72. Anees W., Gannon P.F., Huggins V., Pantin C.F., and Burge P.S. Effect of peak expiratory flow data quantity on diagnostic sensitivity and specificity in occupational asthma. Eur Respir J 23 (2004) 730-734
73. Vandenplas O., and Malo J.L. Inhalation challenges with agents causing occupational asthma. Eur Respir J 10 (1997) 2612-2629
74. Roche N., Morel H., Martel P., and Godard P. Clinical practice guidelines: medical follow-up of patients with asthma - adults and adolescents. Respir Med 99 (2005) 793-815
75. Bousquet J., Bousquet P.J., Godard P., and Daures J.P. The public health implications of asthma. Bull World Health Organ 83 (2005) 548-554
76. Worldwide variations in the prevalence of asthma symptoms: the international study of asthma and allergies in childhood (ISAAC). Eur Respir J 12 (1998) 315-335
77. Asher M.I., Montefort S., Bjorksten B., Lai C.K., Strachan D.P., Weiland S.K., Williams H., and ISAAC Phase Three Study Group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 368 (2006) 733-743
78. Hoffjan S., Nicolae D., and Ober C. Association studies for asthma and atopic diseases: a comprehensive review of the literature. Respir Res 4 (2003) 14